Although ample published evidence exists regarding the use of Vacuum Assisted Closure ‰ (V.A.C. ‰ Therapy) in adults, there is little published evidence and much confusion relating to the use of this treatment modality in children. Recognition of this problem prompted the formation of a group of experts who conducted literature reviews, consulted patients, carers and colleagues, developed consensus opinion, and formulated and tested recommendations for the safe and effective use of V.A.C. ‰ Therapy in patients under the age of 18 years.
The guidance provided in this document relates the use of V.A.C. ‰ Therapy in paediatric patients, that is in neonates, children, and young people less than 18 years of age. indications V.A.C. ‰ Therapy is used in a wide variety of acute and chronic wounds to: n remove exudate and reduce periwound oedema n increase tissue perfusion n promote formation of granulation tissue n reduce the complexity/size of a wound n optimise the wound bed prior to and following surgery n create a closed, moist wound environment 1 .
In paediatric patients, the potential reduction in dressing change frequency associated with V.A.C. ‰ Therapy may have important benefits in reducing anxiety and distress to patients and their parent(s)/carer(s). The nature of the V.A.C. ‰ Therapy dressing provides enhanced dressing security and reduces the likelihood of the patient disrupting or removing the dressing. Box 1 lists paediatric wound types suitable for V.A.C. ‰ Therapy.
In addition to the type of wound and the objectives of treatment, the decision to treat with V.A.C. ‰ Therapy will be influenced by a wide range of other factors. These include the availability of equipment and disposable supplies, and accessibility to suitably trained practitioners to monitor treatment and undertake dressing changes. Such factors may be of critical importance in the community setting and dictate how and whether V.A.C. ‰ Therapy is employed.
The duration of use of V.A.C. ‰ Therapy will vary according to treatment goals and response to treatment. For example, the use of V.A.C. ‰ Therapy to prepare a wound for skin grafting may take only a week or so. For definitive closure of a chronic wound V.A.C. ‰ Therapy may be used for extended periods as long as satisfactory progress is made. V.A.C. ‰ Therapy in paediatric patients must be undertaken only by appropriately trained, competent healthcare practitioners (see page 3; Appendix 1) 
AppLiCAtion to prACtiCE
The guidance in this document should be used in conjunction with the policies and procedures of the relevant healthcare organisation(s) Healthcare practitioners should be fully conversant with the contraindications and cautions for the use of V.A.C. ‰ Therapy in paediatric patients imaging V.A.C. ‰ Therapy dressings and tubing can be left in situ during X-ray, MRI, fluoroscopy or dye tests. However, the V.A.C. ‰ Therapy unit must not be taken into an MRI suite as it may damage the MRI equipment or cause damage to the patient/caregiver. The results of imaging tests for wounds containing silver impregnated foams may be distorted 2 .
Hyperbaric oxygen therapy
The V.A.C. ‰ Therapy dressing may be removed under the direction of the hyperbaric oxygen therapy (HBOT) clinician to allow oxygen into the wound (see page 9 for information on dressing removal). If the dressing is left in situ during HBOT, the unit and canister should be removed, and the tubing clamped and covered according to the manufacturer's guidance 2 .
autHorisation As a minimum, the use of V.A.C. ‰ Therapy for wound management must be authorised by the child's consultant (or designated deputy) and named nurse (or designated deputy) in accordance with local authorisation and/or reimbursement policies.
Consideration of local reimbursement issues is particularly important if the child is to be discharged into the community with V.A.C. ‰ Therapy.
consent During the process of obtaining consent, a full explanation of V.A.C. ‰ Therapy should be given to the child and parent(s)/carer(s), including: n goal(s) of treatment n mode of action n negative pressures to be used n approximate treatment time n advantages, disadvantages and potential side effects n alternative treatment options. ! 2 | PRINCIPLES OF BEST PRACTICE Where possible, an age-appropriate patient information leaflet should be given to the child before consent is obtained, and any questions arising from this answered before therapy starts.
Verbal or written consent for V.A.C. ‰ Therapy should be obtained according to local protocol. Verbal consent must be documented in the child's medical notes.
Discussion of treatment goals during the consent process will assist in managing expectations, and will assist appropriate staff when deciding to end therapy community use Before applying V.A.C. ‰ Therapy to children in the community, or before transfer of a child receiving V.A.C. ‰ Therapy from hospital to community: n the adequacy of haemostasis should be ensured and a low risk of bleeding at the wound site should be established n the suitability of the home environment should be considered n the parent(s)/carer(s) must understand the safety information, and be able to respond to alarms and follow instructions for use n where appropriate, children, parent(s) or carer(s) who wish to manage the therapy should be trained and assessed as competent in accordance with local policy or General Medical Council (GMC) or Nursing and Midwifery Council (NMC) guidelines n the practitioners involved in community care must be conversant with V.A.C. ‰ Therapy and competent to carry out procedures as necessary (see below) n appropriate V.A.C. ‰ Therapy equipment must be used, eg portable units with extended battery life.
Practitioner comPetencies
Appendix 1 (see end of document) outlines the competencies required by hospital and community practitioners to use V.A.C. ‰ Therapy.
In all instances, if the skills are not practised within three months, the practitioner must satisfy his/ herself that their skills are in line with current practice, or seek reassessment.
The practitioner and supervisor should determine the number of supervised practices required to achieve competence, taking into account the learning needs of the practitioner.
Practitioners new to an organisation who wish to undertake V.A.C. ‰ Therapy and who gained competency elsewhere, will need to familiarise themselves with local protocols, and should provide evidence of previous education, training and competency.
Supervisors who deem practitioner competency should fulfil local requirements for the role and themselves: n have suitable experience of V.A.C. ‰ Therapy n be up-to-date with techniques and equipment n be fully conversant with local protocols.
Practitioners must accept responsibility and be accountable for maintaining their competence through regular clinical experience and development of supporting theoretical knowledge 3 
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The following should be assessed before initial application of V.A.C. ‰ Therapy and also at each dressing change: n Wound: Assessment should include documenting the type, site, size, and depth of the wound, the condition of the wound bed and periwound skin, and the amount and characteristics of exudate. Where possible, photography should be used in accordance with Institute of Medical Illustrators (IMI) guidelines to record and monitor wound appearance 4 . See Box 3 for signs of healing progress. n Pain: An agreed and consistently used pain assessment tool should be used to assess pain at and between dressing changes. See pages 11-12 for more information on pain assessment and management. n Psychosocial well-being: The child, family and carer(s) need to understand why V.A.C. ‰ Therapy is required, what therapy comprises and what to expect. The impact of V.A.C. ‰ Therapy on the child and the parent(s)/carer(s) should be evaluated, eg are sleep, mobility, play or social activities being affected (positively or negatively)? n Duration of treatment: Anticipated frequency of foam dressing change (see page 9) and anticipated therapy completion date (if known) should be documented. n Clinical reactions: The child should be monitored for signs of allergic reaction to materials applied to the skin. If reactions occur or sensitivities to components of the dressings are known, the dressing component should be discontinued or not used, and the clinician directing treatment informed. n Nutritional status: Ensuring adequate nutrition is particularly important for patients with chronic wounds and burns. Nutritional supplements should be administered as prescribed. n Size and weight of the patient: Paediatric patients may be at risk of excessive fluid loss and dehydration. Fluid output should be carefully monitored, and fluid from both the canister and tubing measured 2 . Before inclusion of these measurements in fluid balance calculations, account must be taken of any liquid added to the canister when V.A.C. ‰ Therapy was set up or the canister changed (see page 9). Many patient and parent/carer anxieties will relate to pain: analgesia should be administered as prescribed and given sufficient time to become effective before procedures are initiated (see pages 11-12). Distraction techniques (eg computer games, watching television, music, listening to stories) may be very helpful and should be offered and tailored to the requests and needs of the child.
The initial application of V.A.C. ‰ Therapy, subsequent dressing changes and final removal should use universal precautions and be treated as aseptic procedures.
Where possible, child/parent/carer involvement should be encouraged, particularly if it is anticipated that V.A.C. ‰ Therapy will continue for some time
Application guidelines
Ensure consent for treatment has been obtained and documented according to local policy A.C. ‰ Therapy unit n 300ml canister (for safety reasons the 1000ml canister must NOT be used) n Dressings -the type of foam used will be dependent on the wound and the child, although the V.A.C. ‰ WhiteFoam Dressing is generally recommended to prevent growth of granulation tissue into the foam 2 n Wound care pack (as necessary) n Gloves and scissors n Barrier film dressing.
PrePare wound and Periwound area
If already in place, the drape and foam should be removed (see Removal on page 9).
If necessary, the wound should be debrided, and the wound and periwound area irrigated, in accordance with local guidelines.
Only practitioners deemed competent should perform wound debridement 
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A barrier film dressing should be applied to the periwound area. This will help to produce a seal that enables the unit to maintain a negative pressure on the wound.
The wound must have a perimeter of at least 2cm of viable intact skin so that a seal can be maintained* *Where skin is fragile or bridging is necessary, it is possible to use an appropriate dressing, eg a hydrocolloid dressing or V.A.C. ‰ Gel Strips. However, this should be discussed with the child's consultant or a member of the woundcare team.
aPPly tHeraPy Foam
The foam(s) should be cut to the wound dimensions, ensuring the wound base, sides and any undermined areas are covered. The number of pieces of foam inserted into the wound should be documented. Force should not be used to push the foam into the wound, and the foam should not be compressed.
Unless V.A.C. ‰ WhiteFoam Dressing is used, a single layer of wide-meshed, nonadherent material may need to be applied to the wound bed before foam insertion to prevent adherence.
Do not cut the foam larger than the wound. Allowing the foam to overlap the wound margin may lead to excoriation of periwound skin drape The drape should be sized, trimmed and applied to cover the foam dressing and a 2cm periwound border. The drape can be 'patched' as necessary and should not be placed under tension.
Do not apply drape circumferentially to a limb sensat.r.a.c. ‰ pad After a central section of the drape is lifted by pinching up a fold, a 2.5cm hole should be cut in the drape with scissors. The SensaT.R.A.C. ‰ pad should be applied directly over the hole.
Neonates and infants with small wounds may require an additional piece of foam under the SensaT.R.A.C. ‰ pad to prevent pressure damage from the disc.
Gentle pressure can be used to facilitate adhesion of the pad to the drape. The tubing should be secured with tape to the patient to prevent pulling. Checks should be made to ensure that the pad and tubing are not pulling on the wound area or inhibiting patient mobility, handling or pressure area care.
canister
The 300ml canister may be prefilled with a volume of sterile water or sterile saline according to the child's age (Table 1, page 8) before connection to the dressing or unit 2 . Prefilling the canister may allow more accurate measurement of fluid/exudate loss or provide early warning of a rapid or large fluid loss (eg significant bleed). The volume of saline should be documented on the canister to ensure this amount is deducted from the total fluid balance.
! ! !
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Once the canister has been connected to the unit, the dressing tubing should be connected to the canister tubing, and both clamps opened. The unit should be switched on and set to the agreed negative pressure (Table 2) , cycle (ie intermittent or continuous negative pressure) and intensity. In general, continuous negative pressure should be used because intermittent negative pressure enhances granulation tissue formation, which is usually already robust in children. However, the individual child and wound will determine which form of negative pressure is used.
Once the unit has been programmed, the 'therapy on/off' button should be pressed to activate negative pressure and 'collapse' the dressing. Dressing integrity should be ensured by listening for leaks and observing the unit's seal function (if available), and by checking that the drape is smooth.
Consider starting with the lowest recommended negative pressure, because children generally tolerate this better Dressing removal and canister change V.A.C. ‰ Therapy dressings should be changed every 5-7 days when applied to skin grafts or dermal substitutes. For all other wounds, dressings should be changed every 48-72 hours.
If infection is present, dressings should be changed according to exudate level (eg to prevent leakage under the drape), but at least every 48 hours Analgesia and/or distraction techniques should be administered as prescribed and necessary. After raising the tubing connectors above the level of the therapy unit, the clamp on the dressing tubing should be closed with the unit still running. The canister tubing and dressing tubing are separated.
Once the unit has pulled the exudate in the canister tube into the canister, the clamp on the canister tube is closed and the 'therapy on/off' switch is pressed to deactivate the unit. The canister can be changed if required (see below).
The foam should be allowed to decompress completely before the drape is removed.
The drape is removed by gentle stretching parallel to the skin surface and slowly pulling up from the skin. It should not be peeled off. The foam is gently removed from the wound, ensuring that the number of pieces removed tallies with the number inserted.
Dressings should be disposed of according to local infection control protocol.
canister cHange
The canister should be changed using universal precautions when full (usually every 3-5 days), at least once per week, or as suggested by local infection control policy.
The 'therapy on/off' switch should be turned off before canister change. The clamps on both the canister and dressing tubing should be closed. The canister tubing can then be disconnected and the canister removed from the unit and disposed of according to local protocol.
The amount and appearance of the contents should be documented, taking into account the volume of sterile water/saline used to prefill the canister.
The new canister may be prefilled with sterile water or sterile saline according to Table 1 (page 8) and reconnected to the dressing tubing. After both clamps are opened and the pressure, cycle and intensity reset (if appropriate), the 'therapy on/off' button can be pressed to switch on negative pressure.
!
AppLiCAtion to prACtiCE
If the foam adheres to the wound, consider flushing sterile saline through the tubing before drape removal and allowing it to soak into the foam ! VACUUM ASSISTED CLOSURE ‰ IN PAEDIATRICS AND YOUNG PEOPLE | 9 inFection control on discontinuation of V.a.c. ‰ therapy When therapy is discontinued, the V.A.C. ‰ Therapy unit should be cleaned with detergent and water (or a detergent wipe), then an alcohol wipe, and placed in a polythene bag and stored in the black carrying case provided as per manufacturer's instructions. The unit should not be immersed or soaked in liquid. A label should be attached to the outside of the case indicating that the machine has been used and is awaiting collection. The unit should be placed in a designated storage facility. The manufacturer should be contacted for collection and decontamination, and the relevant paperwork completed.
unit contamination
If the child has an infection or an infected wound and the outside of the unit is contaminated, the unit should be disinfected according to local decontamination policy, and/or advice sought from the local infection control team. 
Pain management
The management of pain in children receiving V.A.C.® Therapy has two facets -management of: n wound-related background pain n pain resulting from dressing application or change.
This section provides information on the management of procedural pain. The management of background pain and procedural pain should be considered as separate issues. However, plans to manage procedural pain need to take into account any regimen used for background pain.
Essential to good pain management is accurate, ongoing, consistent and documented assessment of pain that uses an age/developmentally appropriate, preferably validated, rating scale
The pain assessment tool used should be in line with local policy. Further information on pain assessment in paediatric patients can be obtained from: www.rcn.org.uk/childrenspainguideline.
Procedural Pain management
Procedural pain management demands a focused and planned approach that includes all members of the team involved, eg medical and nursing staff, the patient and parent(s)/carer(s). Planning should include the timing and location of the procedure, as this may inform the type and/or availability of safe analgesia/sedation.
Prior to commencing any procedure the patient should be asked if they are experiencing any pain. If pain is present then an appropriate pain assessment tool should be used to identify the intensity of pain.
Paediatric patients respond well to non-drug therapies. These can reduce anxiety, distract and enhance the effect of the pharmacological agents used. As wounds heal and procedures become less invasive, non-drug therapies may be used in isolation, but only after careful assessment of the individual patient. Non-drug therapies include the environment (eg temperature, lighting, location, etc), distraction and focused play (eg the child reading the story rather than the adult reading to the child), and relaxation and guided imagery (where staff trained in these strategies are available).
The type of analgesia used should be chosen on the basis of the degree of invasiveness of the procedure, as well as likely duration. For example, dressing application or change in a wound that is clearly likely to cause significant pain should be undertaken using strong analgesia, eg morphine, Entonox or fentanyl lozenge. These produce some degree of anxiolysis in addition to analgesia.
It is essential that analgesia is given sufficient time to take effect BEFORE commencing the procedure
!
AppLiCAtion to prACtiCE
Appropriate analgesia/distraction therapies should be administered as prescribed and as necessary to manage pain resulting from dressing application or change Paediatric patients experiencing ongoing background pain should be managed by an appropriately trained healthcare professional and according to local guidelines VACUUM ASSISTED CLOSURE ‰ IN PAEDIATRICS AND YOUNG PEOPLE | 11 !
